Bacil Pharma Ltd. - Research Center
524516 BACPHAR Group (XT) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 6.53 | 6.53 | 6.53 | 6.53 | 6.53 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | -5.43 | -5.30 | -5.14 | -5.14 | -4.62 |
| Loan funds | |||||
| Secured loans | 0.02 | 0.03 | 0.18 | 0.17 | 0.10 |
| Unsecured loans | - | - | - | - | - |
| Total | 1.12 | 1.26 | 1.57 | 1.56 | 2.01 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 |
| Net block | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 |
| Capital work-in-progress | - | - | - | - | - |
| Investments | 0.43 | 0.31 | 0.37 | 0.43 | 0.96 |
| Net current assets | |||||
| Current assets, loans & advances | 0.69 | 0.95 | 3.70 | 3.66 | 3.57 |
| Less : current liabilities & provisions | 0.01 | 0.01 | 2.52 | 2.55 | 2.55 |
| Total net current assets | 0.69 | 0.93 | 1.18 | 1.11 | 1.02 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 1.12 | 1.26 | 1.57 | 1.56 | 2.01 |
| Notes: | |||||
| Book value of unquoted investments | 0.43 | 0.31 | 0.37 | 0.43 | 0.55 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | - | - | - | - | - |
| Number of equity sharesoutstanding (Lacs) | 58.90 | 58.90 | 58.90 | 58.90 | 58.90 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis